Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 6/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | SUV39H2 | Q9H5I1 | 4/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25329977 | 0.83 | AR (0.43) | ARMAPTHTR2A | |
| SCHEMBL25328874 | 0.81 | AR (0.60) | AR | |
| SCHEMBL25330105 | 0.78 | AR (0.39) | ARMAPT | |
| SCHEMBL31466633 | 0.78 | CHRM4 (0.51) | ARMAPTCHRM4MEN1KMT2A | |
| SCHEMBL24989042 | 0.76 | ADRB1 (0.51) | — | |
| SCHEMBL17893756 | 0.75 | AR (0.49) | ARMAPTSUV39H2CHRM4MEN1 | |
| SCHEMBL25330058 | 0.74 | AR (0.50) | AR | |
| SCHEMBL25329752 | 0.73 | AR (0.36) | ARMAPTMEN1THRBKMT2A | |
| SCHEMBL25329081 | 0.72 | AR (0.40) | ARMAPTMEN1KMT2A | |
| SCHEMBL4734994 | 0.72 | QDPR (0.46) | ARHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023139199-A1 | COMPOUNDS AND THEIR USE IN TREATING CANCER | ASTRAZENECA AB (SE) | 2023-07-27 | — | — | WO | disclosed |